Monitoring of Chronic Conditions in Breast Cancer

Recruiting Observational Study
Breast Cancer Chronic Fatigue Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 – 80
Sex
Female
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Helse Stavanger HF · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
REBECCA-1 is an observational study. Clinical research is undergoing a revolutionary change. The use of electronic patient records (EHR), digital registers, smartphones etc will create "real-world data" (RWD) that provides great opportunities for advancing clinical research, but so far this opportunity has been little exploited. The REBECCA -1 study will observe and monitor fatigue in breast cance…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Breast cancer patients with histologically detectable M0 breast cancer (stage 0-III) who require neoadjuvant or adjuvant endocrine, chemo and / or radiation therapy at least and no more than 3 months before initiation of study. * Female breast cancer patients between 19 and 80…
Contacts

Tone Hoel Lende, PhD

47861295

leth@SUS.no

CONTACT

Håvard Søiland, PhD

45636028

hsoiland@gmail.com

CONTACT